All
1.
High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma
Albrecht Stenzinger, Volker Endris, Frederick Klauschen, Bruno Sinn, Katja Lorenz, Arne Warth, Benjamin Goeppert, Volker Ehemann, Alexander Muckenhuber, Carsten Kamphues, Marcus Bahra, Peter Neuhaus, Wilko Weichert BMC Cancer 2013, 13 :450 (2 October 2013)
Abstract | Provisional PDF
2.
High-risk human papillomavirus (HPV) DNA sequences in metaplastic breast carcinomas of Mexican women
Roberto Herrera-Goepfert, Teresa Vela-Chávez, Adela Carrillo-García, Marcela Lizano-Soberón, Alfredo Amador-Molina, Luis F Oñate-Ocaña, Rita Sotelo-Regil Hallmann BMC Cancer 2013, 13 :445 (1 October 2013)
Abstract | Provisional PDF
3.
Preoperative neutrophil/lymphocyte ratio predicts overall survival but does not predict recurrence or cancer-specific survival after curative resection of node-positive colorectal cancer
Lucy Jankova, Owen F Dent, Charles Chan, Pierre Chapuis, Stephen J Clarke BMC Cancer 2013, 13 :442 (1 October 2013)
Abstract | Provisional PDF
4.
Expression of activator protein-1 (AP-1) family members in breast cancer
Amirhossein Kharman-Biz, Hui Gao, Reza Ghiasvand, Chunyan Zhao, Kazem Zendehdel, Karin Dahlman-Wright BMC Cancer 2013, 13 :441 (28 September 2013)
Abstract | Full text | PDF
| PubMed
5.
Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer
Vlad Popovici, Eva Budinska, Fred T Bosman, Sabine Tejpar, Arnaud D Roth, Mauro Delorenzi BMC Cancer 2013, 13 :439 (27 September 2013)
Abstract | Full text | PDF
| PubMed
6.
The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: an immunohistochemical study of tissue microarrays
Nilanjana Tewari, Abed M Zaitoun, Arvind Arora, Srinivasan Madhusudan, Mohammad Ilyas, Dileep N Lobo BMC Cancer 2013, 13 :436 (24 September 2013)
Abstract | Full text | PDF
| PubMed
7.
Class III beta-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer
Jun-Eul Hwang, Ji-Yun Hong, Karham Kim, Seung-Hun Kim, Won-Young Choi, Min-Jee Kim, Sung-Hoon Jung, Hyun-Jeong Shim, Woo-Kyun Bae, Eu-Chang Hwang, Kyung-Hwa Lee, Jae-Hyuk Lee, Sang-Hee Cho, Ik-Joo Chung BMC Cancer 2013, 13 :431 (23 September 2013)
Abstract | Provisional PDF
| PubMed
8.
Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin
Peter Bronsert, Ilona Kohler, Martin Werner, Frank Makowiec, Simon Kuesters, Jens Hoeppner, Ulrich Hopt, Tobias Keck, Dirk Bausch, Ulrich Wellner BMC Cancer 2013, 13 :428 (22 September 2013)
Abstract | Full text | PDF
| PubMed
9.
Method validation of circulating tumour cell enumeration at low cell counts
Jeffrey Cummings, Karen Morris, Cong Zhou, Robert Sloane, Matt Lancashire, Daniel Morris, Stephen Bramley, Matt Krebs, Leila Khoja, Caroline Dive BMC Cancer 2013, 13 :415 (11 September 2013)
Abstract | Full text | PDF
| ePUB | PubMed
10.
ITGA3 and ITGB4 expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma
Masaki Nagata, Arhab A Noman, Kenji Suzuki, Hiroshi Kurita, Makoto Ohnishi, Tokio Ohyama, Nobutaka Kitamura, Takanori Kobayashi, Kohya Uematsu, Katsu Takahashi, Naoki Kodama, Tomoyuki Kawase, Hideyuki Hoshina, Nobuyuki Ikeda, Susumu Shingaki, Ritsuo Takagi BMC Cancer 2013, 13 :410 (5 September 2013)
Abstract | Full text | PDF
| ePUB | PubMed
